Arcadia Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Arcadia Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-65	Closed	-$8K	–	286
2020 Q2	$8K	Hold	65	–	–	﹤0.01%	252
2020 Q1	$6K	Hold	65	–	–	﹤0.01%	280
2019 Q4	$7K	Hold	65	–	–	﹤0.01%	271
2019 Q3	$7K	Hold	65	–	–	﹤0.01%	280
2019 Q2	$11K	Buy	65 +15	+30%	+$2.59K	﹤0.01%	292
2019 Q1	$8K	Hold	50	–	–	﹤0.01%	268
2018 Q4	$5K	Hold	50	–	–	﹤0.01%	267
2018 Q3	$9K	Hold	50	–	–	﹤0.01%	308
2018 Q2	$7K	Hold	50	–	–	﹤0.01%	317
2018 Q1	$6K	Hold	50	–	–	﹤0.01%	330
2017 Q4	$7K	Buy	+50	New	+$5.88K	﹤0.01%	339

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Arcadia Investment Management's GWPH Position: Q3 2020 in Review

Arcadia Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 65 shares — an estimated $8K sold.

Arcadia Investment Management first reported a position in GWPH in Q4 2017 and held it in 11 quarters. The position peaked at $11K in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

Arcadia Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Arcadia Investment Management sold 65 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $8K.
Arcadia Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 11 quarters.
Arcadia Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $11K in Q2 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Arcadia Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.